I85PREP
⌘ K
EDiR study materials
EDiR study resources

A 20 mm pancreatic head cyst in a fit 66-year-old: how far do you push?

EDiR · Put your knowledge to work in context.

All case studies

A 20 mm pancreatic head cyst in a fit 66-year-old: how far do you push?

A 66-year-old man undergoes unenhanced CT of the abdomen for visible haematuria. The urinary tract is normal, but there is an incidental 20 mm unilocular cystic lesion in the pancreatic head. There is no dilatation of the main pancreatic duct, no calcification, no solid component and no lymphadenopathy. He has no abdominal symptoms, no history of pancreatitis, no family history of pancreatic cancer, and his HbA1c is normal. CA 19-9 is 12 U/mL. He is otherwise fit, with hypertension controlled on a single agent. The urology team has discharged him and asks you to advise on the pancreatic finding.

1. Which single imaging test would you perform next, and which specific features are you trying to demonstrate?

Read the worked answer

MRI of the pancreas with MRCP (T2-weighted and heavily T2-weighted sequences, DWI, and a post-gadolinium series).

Why not repeat CT or go straight to EUS:

  • CT has already answered the 'is there a mass?' question; repeating it adds radiation and CT is less sensitive than MRI for thin septa, small mural nodules and duct communication.
  • MRI with MRCP is non-invasive and, in one study, gives the anatomical information needed to classify the cyst in the large majority of cases.

What I am specifically looking for:

  • Communication with the duct system - the single most useful discriminator between a branch-duct IPMN and a non-communicating cyst.
  • Main duct calibre (and any abrupt calibre change with distal atrophy).
  • Mural nodules - and whether they enhance.
  • Septations, wall thickness, size and any solid component.
  • Number and location of cysts - a cluster of small cysts in the head in an older patient suggests a branch-duct IPMN or a serous cystadenoma; a unilocular cyst in the body/tail of a woman raises the possibility of a mucinous cystic neoplasm.

EUS is reserved for when MRI is non-diagnostic, or if worrisome features appear.

2. MRI confirms a 20 mm unilocular cyst communicating with a non-dilated side branch, with no nodule and no main duct dilatation. What is your diagnosis and surveillance plan, and how confident are you?

Read the worked answer

Branch-duct IPMN without worrisome features. The duct communication is what secures this; without it I would be much less certain and would keep mucinous cystic neoplasm and a simple/retention cyst in the differential.

Surveillance:

  • MRI/MRCP (or a mixture of MRI and EUS) at 6 months, then annually if stable. The 2 cm size sits right at a guideline boundary - several schemes move from 'annual MRI' to 'alternating MRI and EUS' at 2–3 cm - so this is a defensible juncture rather than a single correct answer, and I would say so to the patient.
  • I would not send this patient for surgery, and I would not biopsy it.

Counselling points and reasoning:

  • The absolute risk of progression to high-grade dysplasia or cancer in a small BD-IPMN without worrisome features is low - of the order of a few per cent over 5 years - so the burden of annual imaging must be weighed against a real but small risk.
  • He is fit with a good life expectancy, which is precisely the situation where surveillance pays off; in a frail 85-year-old I would shorten or abandon the programme.
  • He should be told to report new jaundice, weight loss, steatorrhoea or new diabetes promptly rather than waiting for the next scan.

3. Two years later the cyst measures 26 mm and he mentions new-onset diabetes. What do you do now, and what are the limits of that step?

Read the worked answer

This is now a cyst with a worrisome feature and it should be re-evaluated by a pancreatic multidisciplinary team.

Why:

  • Growth (a rate of roughly 5 mm/year or more is the usual threshold; 6 mm over 2 years is borderline but the trend matters) plus new-onset diabetes are both recognised worrisome features. New diabetes is a soft marker and could easily be coincidental in a 68-year-old, but in this context it must be taken seriously.
  • The next step is EUS to look for mural nodules and main duct involvement, with FNA for cytology, CEA and amylase if a nodule or solid component is seen.

Limits of what EUS and FNA can tell you:

  • Cyst fluid CEA is suggestive but not diagnostic of a mucinous cyst, and cytology is frequently non-diagnostic; a negative FNA does not exclude malignancy.
  • Sampling a cystic lesion carries a small risk of leakage/infection and gives poor negative predictive value - it changes management when positive far more often than when negative.

Decision:

  • If EUS shows an enhancing nodule or main duct involvement, offer resection (pancreatoduodenectomy) after discussing the substantial operative morbidity against the risk of an undiagnosed cancer.
  • If EUS is negative, shortening the surveillance interval to 6 months and continuing MDT review is reasonable, but the growth trend should not be dismissed just because the cytology is benign.